(Qiagen, Valencia, CA) and RNA (5 μg) was reverse transcribed with Invitrogen’s SuperScript® III First-Strand
Synthesis System. RT-qPCR was performed using TaqMan rat CYP1A1, CYP1B1, and ACTB primers with FAM/MGB probe (Applied Biosystems,
Carlsbad, CA) as described previously (29 (link)). MCF-10A cells were obtained from ATCC
(Manassas, VA) and authenticated via STR profiling (Promega). MCF-10A cells were cultured as described previously (29 (link)). For the in vitro CYP1A1/CYP1B1 induction experiments, cells having approximately
15 through 20 passages were plated in 96-well plates and treated with vehicle (DMSO), GG, GI, and licorice compounds for 24 h.
RT-qPCR was performed as previously described (29 (link)) using TaqMan® 1-Step RT-PCR
Master Mix, and CYP1A1 and CYP1B1 primer with FAM-MGB probe and GAPDH primer with VIC-MGB probe. Data were analyzed with the
comparative CT (ΔΔCT) method and expressed as fold induction
relative to the vehicle control group.